Literature DB >> 3930719

Class specific rheumatoid factors in rheumatoid arthritis: response to chrysotherapy and relationship to disease activity.

S R Rudge, J D Pound, D H Bossingham, R J Powell.   

Abstract

IgG rheumatoid factors (RF) may play an important role in the pathogenesis of rheumatoid arthritis (RA). Our study investigates the relationship between class specific RF levels measured by radioimmunoassay and disease activity in patients with RA undergoing chrysotherapy. Nineteen patients were treated with 20 mg disodium aurothiomalate weekly for 6 months. Rheumatoid disease activity was assessed before and after 6 months' treatment and the level of IgG, IgA and IgM RF measured. There were significant falls in disease activity (p less than 0.005), IgA RF (p less than 0.005) IgG RF (p less than 0.005) and SCAT (p less than 0.025), but not IgM RF, over the 6 month treatment period. No correlation was found between absolute levels of IgA, IgG or IgM RF and disease activity before or after 6 months' therapy but there was a highly significant linear correlation between reduction in IgG RF levels and fall in disease activity (r = 0.642, p less than 0.005) with treatment.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3930719

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  Significance of rheumatoid factors in an eight-year longitudinal study on arthritis.

Authors:  T Tuomi; K Aho; T Palosuo; K Kaarela; R von Essen; H Isomäki; M Leirisalo-Repo; S Sarna
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

2.  Clinical value of ELISA assays for IgM and IgG rheumatoid factors.

Authors:  R Stone; J S Coppock; P T Dawes; P A Bacon; D L Scott
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

Review 3.  Is measurement of rheumatoid factor isotypes clinically useful?

Authors:  T Jónsson; H Valdimarsson
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

4.  Population study of the importance of rheumatoid factor isotypes in adults.

Authors:  T Jónsson; J Thorsteinsson; A Kolbeinsson; E Jónasdóttir; N Sigfússon; H Valdimarsson
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

5.  Disease activity and joint damage progression in early rheumatoid arthritis: relation to IgG, IgA, and IgM rheumatoid factor.

Authors:  K B Eberhardt; L Truedsson; H Pettersson; B Svensson; L Stigsson; J L Eberhardt; F A Wollheim
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

6.  Rheumatoid factor tests in the diagnosis and prediction of rheumatoid arthritis.

Authors:  D J Walker; J D Pound; I D Griffiths; R J Powell
Journal:  Ann Rheum Dis       Date:  1986-08       Impact factor: 19.103

7.  Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study.

Authors:  D van Zeben; J M Hazes; A H Zwinderman; A Cats; E A van der Voort; F C Breedveld
Journal:  Ann Rheum Dis       Date:  1992-09       Impact factor: 19.103

8.  ELISA assays for IgM and IgG rheumatoid factors: their clinical correlations during therapy with slow-acting anti-rheumatic drugs.

Authors:  D L Scott; P T Dawes; M Collins; R Stone
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.